Generic Name: Sacubitril/valsartan
Brand Name: Entresto
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Indications: Heart failure, NYHA class II or III
Submission Type: New
Project Status: Complete
Date Recommendation Issued: March 18, 2016
Recommendation Type: List with clinical criteria and/or conditions
Request for Resubmission: Eligible (January 6, 2020)